Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring

Objectives: The feasibility of measuring bradykinesia and chorea in Huntington's Disease using a wearable sensor system (Parkinson’s Kinetigraph: PKG) developed for measuring bradykinesia and dyskinesia in Parkinson’s Disease was assessed. Methods: Unified Huntington’s Disease Rating Scales (UH...

Full description

Bibliographic Details
Main Authors: Katya Kotschet, Sarah Osborn, Malcolm Horne
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Clinical Parkinsonism & Related Disorders
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590112522000500
_version_ 1797827760526196736
author Katya Kotschet
Sarah Osborn
Malcolm Horne
author_facet Katya Kotschet
Sarah Osborn
Malcolm Horne
author_sort Katya Kotschet
collection DOAJ
description Objectives: The feasibility of measuring bradykinesia and chorea in Huntington's Disease using a wearable sensor system (Parkinson’s Kinetigraph: PKG) developed for measuring bradykinesia and dyskinesia in Parkinson’s Disease was assessed. Methods: Unified Huntington’s Disease Rating Scales (UHDRS) and a PKG were obtained for 25 people with Huntington's Disease. Bradykinesia and Chorea Score were derived from relevant sub-scores of the UHDRS and compared with the PKG’s bradykinesia and dyskinesia scores. The PKG’s daytime sleepiness score was also used. Results: There was good correlation between Chorea Scores and the PKG’s dyskinesia score (Pearson’s ρ = 0.66). Correlation between the Bradykinesia Scores and the PKG’s bradykinesia score was also good (Pearson’s ρ = 0.51) in cases whose PKG scores were in the normal or bradykinetic range. The PKG’s bradykinesia score of 23, which is in the higher range of control subjects, separated participants into those with Independence Score ≥ 80 or < 80 and a Functional Assessment (FAS) score ≥ 18 or < 18. The PKG’s daytime sleep score was high in 44 % of participants, whose average time asleep was 21 % compared to 1.6 % in participants with a normal sleep index. Participants with high sleep scores were significantly more likely to have low Independence and TFC scores. Conclusions: Measures of bradykinesia and dyskinesia from clinical scales have acceptable correlations with those from the PKG. Continuous monitoring provides information about daytime sleep, which was associated with lower functional status. Further studies and larger sample sizes are required to confirm these findings and the utility of this measure in Huntington's Disease.
first_indexed 2024-04-09T12:53:32Z
format Article
id doaj.art-2a713896b93b4b3487190b47655c2fcf
institution Directory Open Access Journal
issn 2590-1125
language English
last_indexed 2024-04-09T12:53:32Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Clinical Parkinsonism & Related Disorders
spelling doaj.art-2a713896b93b4b3487190b47655c2fcf2023-05-14T04:29:29ZengElsevierClinical Parkinsonism & Related Disorders2590-11252023-01-018100179Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoringKatya Kotschet0Sarah Osborn1Malcolm Horne2Department of Clinical Neurosciences, St Vincent’s Hospital, Fitzroy, Vic, AustraliaDepartment of Clinical Neurosciences, St Vincent’s Hospital, Fitzroy, Vic, Australia; 3065Parkinsons Laboratory, Florey Institute of Neurosciences and Mental Health, Parkville, Vic 3010, AustraliaDepartment of Clinical Neurosciences, St Vincent’s Hospital, Fitzroy, Vic, Australia; 3065Parkinsons Laboratory, Florey Institute of Neurosciences and Mental Health, Parkville, Vic 3010, Australia; Corresponding author at: Department of Clinical Neurosciences, St Vincent’s Hospital, Fitzroy, Vic, Australia (M. Home).Objectives: The feasibility of measuring bradykinesia and chorea in Huntington's Disease using a wearable sensor system (Parkinson’s Kinetigraph: PKG) developed for measuring bradykinesia and dyskinesia in Parkinson’s Disease was assessed. Methods: Unified Huntington’s Disease Rating Scales (UHDRS) and a PKG were obtained for 25 people with Huntington's Disease. Bradykinesia and Chorea Score were derived from relevant sub-scores of the UHDRS and compared with the PKG’s bradykinesia and dyskinesia scores. The PKG’s daytime sleepiness score was also used. Results: There was good correlation between Chorea Scores and the PKG’s dyskinesia score (Pearson’s ρ = 0.66). Correlation between the Bradykinesia Scores and the PKG’s bradykinesia score was also good (Pearson’s ρ = 0.51) in cases whose PKG scores were in the normal or bradykinetic range. The PKG’s bradykinesia score of 23, which is in the higher range of control subjects, separated participants into those with Independence Score ≥ 80 or < 80 and a Functional Assessment (FAS) score ≥ 18 or < 18. The PKG’s daytime sleep score was high in 44 % of participants, whose average time asleep was 21 % compared to 1.6 % in participants with a normal sleep index. Participants with high sleep scores were significantly more likely to have low Independence and TFC scores. Conclusions: Measures of bradykinesia and dyskinesia from clinical scales have acceptable correlations with those from the PKG. Continuous monitoring provides information about daytime sleep, which was associated with lower functional status. Further studies and larger sample sizes are required to confirm these findings and the utility of this measure in Huntington's Disease.http://www.sciencedirect.com/science/article/pii/S2590112522000500Huntington’s DiseaseWearable sensorsBiosensorsMovement disordersDaytime sleep
spellingShingle Katya Kotschet
Sarah Osborn
Malcolm Horne
Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring
Clinical Parkinsonism & Related Disorders
Huntington’s Disease
Wearable sensors
Biosensors
Movement disorders
Daytime sleep
title Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring
title_full Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring
title_fullStr Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring
title_full_unstemmed Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring
title_short Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring
title_sort measurement of bradykinesia and chorea in huntington s disease using ambulatory monitoring
topic Huntington’s Disease
Wearable sensors
Biosensors
Movement disorders
Daytime sleep
url http://www.sciencedirect.com/science/article/pii/S2590112522000500
work_keys_str_mv AT katyakotschet measurementofbradykinesiaandchoreainhuntingtonsdiseaseusingambulatorymonitoring
AT sarahosborn measurementofbradykinesiaandchoreainhuntingtonsdiseaseusingambulatorymonitoring
AT malcolmhorne measurementofbradykinesiaandchoreainhuntingtonsdiseaseusingambulatorymonitoring